John Gribben, MD, DSc, FRCP, FRCPath, FMediSci

5:24

Drs. John Gribben and Nathan Fowler discuss the promise and pitfalls of immunotherapy in lymphoma, and consider how treatment for lymphoma is impacted by the tumor-immune microenvironment, and may benefit from personalized combination immunotherapy